Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1991;19(2):99-103.
doi: 10.1007/BF00368184.

Cross-resistance patterns related to glutathione metabolism in primary human renal cell carcinoma

Affiliations
Comparative Study

Cross-resistance patterns related to glutathione metabolism in primary human renal cell carcinoma

G Mickisch et al. Urol Res. 1991.

Abstract

In 59 cases of primary human renal cell carcinoma (RCC), cross-resistance and collateral susceptibility patterns were determined in an MTT microculture assay. Concomitantly, the glutathione (GSH) content and the enzymatic activity of gamma-glutamyl transpeptidase (GGT) were measured as distinct resistance characteristics. Resistance or chemoresponse towards Vinca alkaloids and anthracyclines were found to be highly coincident, suggesting that the classical multidrug resistance mechanism is active in human RCC. Strong resistance to platinum complexes combined with relative sensitivity to bleomycin was significantly associated with elevated glutathione levels, providing evidence for another pathway instigating chemoresistance. In contrast, despite substantial enzymatic activity, GGT effects revealed no correlation to the chemoresistance pattern. This result implies that it is the GSH-linked binding and reduction potential rather than the GGT-associated transportation capacity that has an impact on the expression of chemoresistance in human RCC.

PubMed Disclaimer

References

    1. J Natl Cancer Inst. 1988 Mar 2;80(1):14-20 - PubMed
    1. Br J Haematol. 1989 Jan;71(1):19-24 - PubMed
    1. Br J Cancer. 1984 Nov;50(5):625-31 - PubMed
    1. Cancer Res. 1988 Feb 1;48(3):589-601 - PubMed
    1. J Natl Cancer Inst. 1989 Jan 18;81(2):116-24 - PubMed

Publication types

MeSH terms

LinkOut - more resources